pCBFRE-luc Citations (10)
Originally described in: Notch signaling activation in human embryonic stem cells is required for embryonic, but not trophoblastic, lineage commitment.Yu X, Zou J, Ye Z, Hammond H, Chen G, Tokunaga A, Mali P, Li YM, Civin C, Gaiano N, Cheng L Cell Stem Cell. 2008 May 8. 2(5):461-71. PubMed Journal
Articles Citing pCBFRE-luc
| Articles |
|---|
| Cutaneous papillomavirus E6 oncoproteins associate with MAML1 to repress transactivation and NOTCH signaling. Brimer N, Lyons C, Wallberg AE, Vande Pol SB. Oncogene. 2012 Oct 25;31(43):4639-46. doi: 10.1038/onc.2011.589. Epub 2012 Jan 16. PubMed |
| HES6 promotes prostate cancer aggressiveness independently of Notch signalling. Carvalho FL, Marchionni L, Gupta A, Kummangal BA, Schaeffer EM, Ross AE, Berman DM. J Cell Mol Med. 2015 Jul;19(7):1624-36. doi: 10.1111/jcmm.12537. Epub 2015 Apr 12. PubMed |
| Downregulation of RND3/RhoE in glioblastoma patients promotes tumorigenesis through augmentation of notch transcriptional complex activity. Liu B, Lin X, Yang X, Dong H, Yue X, Andrade KC, Guo Z, Yang J, Wu L, Zhu X, Zhang S, Tian D, Wang J, Cai Q, Chen Q, Mao S, Chen Q, Chang J. Cancer Med. 2015 Jun 24. doi: 10.1002/cam4.484. PubMed |
| Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation. Welte T, Kim IS, Tian L, Gao X, Wang H, Li J, Holdman XB, Herschkowitz JI, Pond A, Xie G, Kurley S, Nguyen T, Liao L, Dobrolecki LE, Pang L, Mo Q, Edwards DP, Huang S, Xin L, Xu J, Li Y, Lewis MT, Wang T, Westbrook TF, Rosen JM, Zhang XH. Nat Cell Biol. 2016 Jun;18(6):632-44. doi: 10.1038/ncb3355. Epub 2016 May 16. PubMed |
| C-terminal deletion of NOTCH1 intracellular domain (N1(ICD)) increases its stability but does not amplify and recapitulate N1(ICD)-dependent signalling. Blain J, Bedard J, Thompson M, Boisvert FM, Boucher MJ. Sci Rep. 2017 Jul 11;7(1):5034. doi: 10.1038/s41598-017-05119-0. PubMed |
| MIB1 mutations reduce Notch signaling activation and contribute to congenital heart disease. Li B, Yu L, Liu D, Yang X, Zheng Y, Gui Y, Wang H. Clin Sci (Lond). 2018 Dec 5;132(23):2483-2491. doi: 10.1042/CS20180732. Print 2018 Dec 12. PubMed |
| Atypical chemokine receptor ACKR3/CXCR7 controls postnatal vasculogenesis and arterial specification by mesenchymal stem cells via Notch signaling. Wei ST, Huang YC, Hsieh ML, Lin YJ, Shyu WC, Chen HC, Hsieh CH. Cell Death Dis. 2020 May 4;11(5):307. doi: 10.1038/s41419-020-2512-2. PubMed |
| Viruses harness YxxO motif to interact with host AP2M1 for replication: A vulnerable broad-spectrum antiviral target. Yuan S, Chu H, Huang J, Zhao X, Ye ZW, Lai PM, Wen L, Cai JP, Mo Y, Cao J, Liang R, Poon VK, Sze KH, Zhou J, To KK, Chen Z, Chen H, Jin DY, Chan JF, Yuen KY. Sci Adv. 2020 Aug 28;6(35):eaba7910. doi: 10.1126/sciadv.aba7910. eCollection 2020 Aug. PubMed |
| Biliverdin reductase B impairs cholangiocarcinoma cell motility by inhibiting the Notch/Snail signaling pathway. Gao Z, Ni X, Zheng B, Sun W, Wan W, Liu H, Ni X, Suo T, Li N, Liu H, Shen S. J Cancer. 2022 Apr 4;13(7):2159-2170. doi: 10.7150/jca.70323. eCollection 2022. PubMed |
| De novo pyrimidine synthesis fuels glycolysis and confers chemoresistance in gastric cancer. He D, Chen M, Chang L, Gu J, Liu F, Gao X, Ruan Y. Cancer Lett. 2022 Nov 28;549:215837. doi: 10.1016/j.canlet.2022.215837. Epub 2022 Jul 31. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.